Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MORACTO 1: Tiotropium + Olodaterol FDC in COPD
NCT01533922Phase 3Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Mar 2012
- Primary completion
- Nov 2013
- Modality
- Small Molecules
- Countries
- 10
01
Overview
A Phase 3 trial of tiotropium, olodaterol in chronic obstructive pulmonary disease (COPD), sponsored by Boehringer Ingelheim. Started Mar 2012; status: completed.
02
Drugs
tiotropiumolodaterol
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT01533922.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01533922.